LobbyingDexcom lobbying by quarter
Dexcom DXCM's latest lobbying report covers Q2 2026, at $575K. The four quarters Q4 2025–Q3 2026 total $1.7M. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
DexcomDXCM
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.7M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $112K | 3 |
| Q1 2023 | $117.5K | 2 |
| Q2 2023 | $117.5K | 2 |
| Q3 2023 | $106.5K | 2 |
| Q4 2023 | $106.5K | 2 |
| Q1 2024 | $210K | 2 |
| Q2 2024 | $220K | 2 |
| Q3 2024 | $200K | 3 |
| Q4 2024 | $360K | 3 |
| Q1 2025 | $370K | 3 |
| Q2 2025 | $465K | 4 |
| Q3 2025 | $545K | 4 |
| Q4 2025 | $555K | 4 |
| Q1 2026 | $545K | 4 |
| Q2 2026 | $575K | 5 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$1.8M · 36 reports
- Health issues$1.6M · 32 reports
- Trade$930K · 10 reports
- Medical research and clinical labs$187.5K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES36 reports
- SENATE36 reports
- Centers For Medicare and Medicaid Services (CMS)27 reports
- Health & Human Services, Dept of (HHS)18 reports
- Executive Office of the President (EOP)6 reports
- Office of Management & Budget (OMB)3 reports
- Food & Drug Administration (FDA)2 reports
- Commerce, Dept of (DOC)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseDexcom | $3.1M | 15 quarters |
| Alston & Bird | $720K | 15 quarters |
| Continental Strategy | $375K | 5 quarters |
| Farragut Partners | $370K | 8 quarters |
| BGR Government Affairs | $40K | 1 quarters |
| Squire Patton Boggs | $0 | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHARLIE CHAPMAN | Policy Advisor, HHS; Special Asst, HHS; Prof Staff Member, House Budget Committee; LA, House Budget Committee; Staff Asst, House Ways and Means Committee; Intern, House Ways and Means Committee | Q2 2026 |
| CHRIS KELLY | Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. Blackburn | Q2 2026 |
| CONSTANTINE HINGSON | Chief of Staff, Senator Dan Coats; Counsel/Legislative Director, Senator Judd Gregg; General Counsel, Senator Elizabeth Dole | Q2 2026 |
| DYLAN MOORE | Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8); Intern, Rep. Mike Turner (OH-10) | Q2 2026 |
| EDWARD WHITFIELD | U.S. Representative (21 yrs.) | Q2 2026 |
| JEFFERY C. MORTIER | Prof Staff on E&C Cmte LA Rep Whitfield and Intern Devin Nunes | Q2 2026 |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (RTexas) | Q2 2026 |
| JOHN STONE | Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C | Q2 2026 |
| KRISTEN BAUTZ | Senior Advisor and Special Projects Coordinator, Rep Wasserman Shultz | Q2 2026 |
| SARAH WALTER | Former Legislative Director/Chief Counsel, Sen. John Breaux | Q2 2026 |
| ASHLEY MENZLER | Staff Asst/LC, 1/17-3/18, Office of Rep. Bill Long; LA, 3/18-4/19, Office of Rep. Mike Bost; Scheduler/Dept CoS, 2/20-1/23, Chief of Staff, 1/23-8/24, Office of Rep. Guy Reschenthaler | Q4 2024 |
| BILLY RAINES | Office of Congressman John Boccieri 2010-2011; Office of Congresswoman Betty Sutton 2011-2012 | Q1 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | BGR Government Affairs | $40K |
| 07/20for Q2 | In-house | $370K |
| 07/20for Q2 | Alston & Bird | $40K |
| 07/20for Q2 | Farragut Partners | $50K |
| 07/19for Q2 | Continental Strategy | $75K |
| 06/15for Q2 | BGR Government Affairs | Under $5,000 |
| 04/20for Q1 | In-house | $380K |
| 04/20for Q1 | Alston & Bird | $40K |
| 04/20for Q1 | Farragut Partners | $50K |
| 04/18for Q1 | Continental Strategy | $75K |
| 01/20for Q4 2025 | In-house | $390K |
| 01/20for Q4 2025 | Farragut Partners | $50K |
| 01/20for Q4 2025 | Alston & Bird | $40K |
| 01/19for Q4 2025 | Continental Strategy | $75K |
| 25/10/20for Q3 2025 | In-house | $370K |
| 25/10/20for Q3 2025 | Farragut Partners | $50K |
| 25/10/20for Q3 2025 | Continental Strategy | $75K |
| 25/10/20for Q3 2025 | Alston & Bird | $50K |
| 25/07/21for Q2 2025 | In-house | $290K |
| 25/07/21for Q2 2025 | Alston & Bird | $50K |